150 related articles for article (PubMed ID: 22268426)
21. The combination of colesevelam with sitagliptin enhances glycemic control in diabetic ZDF rat model.
Shang Q; Liu MK; Saumoy M; Holst JJ; Salen G; Xu G
Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G815-23. PubMed ID: 22281473
[TBL] [Abstract][Full Text] [Related]
22. Effect of bariatric surgery combined with medical therapy versus intensive medical therapy or calorie restriction and weight loss on glycemic control in Zucker diabetic fatty rats.
Abegg K; Corteville C; Docherty NG; Boza C; Lutz TA; Muñoz R; le Roux CW
Am J Physiol Regul Integr Comp Physiol; 2015 Feb; 308(4):R321-9. PubMed ID: 25540099
[TBL] [Abstract][Full Text] [Related]
23. Hypoglycaemic effects of methanolic extract of Canscora decussata (Schult) whole-plant in normal and alloxan-induced diabetic rabbits.
Irshad N; Akhtar MS; Bashir S; Hussain A; Shafiq M; Iqbal J; Malik A
Pak J Pharm Sci; 2015 Jan; 28(1):167-74. PubMed ID: 25553693
[TBL] [Abstract][Full Text] [Related]
24. Imeglimin preserves islet β-cell mass in Type 2 diabetic ZDF rats.
Hallakou-Bozec S; Kergoat M; Moller DE; Bolze S
Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00193. PubMed ID: 33855202
[TBL] [Abstract][Full Text] [Related]
25. Exenatide Treatment Alone Improves β-Cell Function in a Canine Model of Pre-Diabetes.
Ionut V; Woolcott OO; Mkrtchyan HJ; Stefanovski D; Kabir M; Iyer MS; Liu H; Castro AV; Wu Q; Broussard JL; Kolka CM; Asare-Bediako I; Bergman RN
PLoS One; 2016; 11(7):e0158703. PubMed ID: 27398720
[TBL] [Abstract][Full Text] [Related]
26. The anti-diabetic effects of GLP-1-gastrin dual agonist ZP3022 in ZDF rats.
Skarbaliene J; Secher T; Jelsing J; Ansarullah ; Neerup TS; Billestrup N; Fosgerau K
Peptides; 2015 Jul; 69():47-55. PubMed ID: 25849341
[TBL] [Abstract][Full Text] [Related]
27. Gastric Bypass-Related Effects on Glucose Control, β Cell Function and Morphology in the Obese Zucker Rat.
Seyfried F; Miras AD; Rotzinger L; Nordbeck A; Corteville C; Li JV; Schlegel N; Hankir M; Fenske W; Otto C; Jurowich C
Obes Surg; 2016 Jun; 26(6):1228-36. PubMed ID: 26377340
[TBL] [Abstract][Full Text] [Related]
28. Retinoid X receptor agonists have anti-obesity effects and improve insulin sensitivity in Zucker fa/fa rats.
Liu YL; Sennitt MV; Hislop DC; Crombie DL; Heyman RA; Cawthorne MA
Int J Obes Relat Metab Disord; 2000 Aug; 24(8):997-1004. PubMed ID: 10951538
[TBL] [Abstract][Full Text] [Related]
29. Energy loss via urine and faeces--a combustive analysis in diabetic rats and the impact of antidiabetic treatment on body weight.
Elvert R; Wille A; Wandschneider J; Werner U; Glombik H; Herling AW
Diabetes Obes Metab; 2013 Apr; 15(4):324-34. PubMed ID: 23121319
[TBL] [Abstract][Full Text] [Related]
30. Aldosterone Synthase Inhibition Improves Glucose Tolerance in Zucker Diabetic Fatty (ZDF) Rats.
Hofmann A; Brunssen C; Peitzsch M; Martin M; Mittag J; Jannasch A; Engelmann F; Brown NF; Weldon SM; Huber J; Streicher R; Deussen A; Eisenhofer G; Bornstein SR; Morawietz H
Endocrinology; 2016 Oct; 157(10):3844-3855. PubMed ID: 27526033
[TBL] [Abstract][Full Text] [Related]
31. Roux-en Y gastric bypass is superior to duodeno-jejunal bypass in improving glycaemic control in Zucker diabetic fatty rats.
Seyfried F; Bueter M; Spliethoff K; Miras AD; Abegg K; Lutz TA; le Roux CW
Obes Surg; 2014 Nov; 24(11):1888-95. PubMed ID: 24927690
[TBL] [Abstract][Full Text] [Related]
32. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
[TBL] [Abstract][Full Text] [Related]
33. Capsaicin-sensitive sensory fibers in the islets of Langerhans contribute to defective insulin secretion in Zucker diabetic rat, an animal model for some aspects of human type 2 diabetes.
Gram DX; Ahrén B; Nagy I; Olsen UB; Brand CL; Sundler F; Tabanera R; Svendsen O; Carr RD; Santha P; Wierup N; Hansen AJ
Eur J Neurosci; 2007 Jan; 25(1):213-23. PubMed ID: 17241282
[TBL] [Abstract][Full Text] [Related]
34. Cholestyramine reverses hyperglycemia and enhances glucose-stimulated glucagon-like peptide 1 release in Zucker diabetic fatty rats.
Chen L; McNulty J; Anderson D; Liu Y; Nystrom C; Bullard S; Collins J; Handlon AL; Klein R; Grimes A; Murray D; Brown R; Krull D; Benson B; Kleymenova E; Remlinger K; Young A; Yao X
J Pharmacol Exp Ther; 2010 Jul; 334(1):164-70. PubMed ID: 20413600
[TBL] [Abstract][Full Text] [Related]
35. Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and zucker diabetic fatty rats and effects of rosiglitazone.
Cai XJ; Lister CA; Buckingham RE; Pickavance L; Wilding J; Arch JR; Wilson S; Williams G
Brain Res Mol Brain Res; 2000 Apr; 77(1):131-7. PubMed ID: 10814839
[TBL] [Abstract][Full Text] [Related]
36. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death.
Finegood DT; McArthur MD; Kojwang D; Thomas MJ; Topp BG; Leonard T; Buckingham RE
Diabetes; 2001 May; 50(5):1021-9. PubMed ID: 11334404
[TBL] [Abstract][Full Text] [Related]
37. Voluntary running exercise prevents β-cell failure in susceptible islets of the Zucker diabetic fatty rat.
Delghingaro-Augusto V; Décary S; Peyot ML; Latour MG; Lamontagne J; Paradis-Isler N; Lacharité-Lemieux M; Akakpo H; Birot O; Nolan CJ; Prentki M; Bergeron R
Am J Physiol Endocrinol Metab; 2012 Jan; 302(2):E254-64. PubMed ID: 22045312
[TBL] [Abstract][Full Text] [Related]
38. Reduced food intake is the major contributor to the protective effect of rimonabant on islet in established obesity-associated type 2 diabetes.
Jin SM; Oh BJ; Lee S; Choi JM; Yang SJ; Park SW; Kim KW; Kim JH; Park CY
Yonsei Med J; 2013 Sep; 54(5):1127-36. PubMed ID: 23918561
[TBL] [Abstract][Full Text] [Related]
39. Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in Zucker diabetic fatty rats: A comparison with PPAR gamma agonism.
Bergeron R; Yao J; Woods JW; Zycband EI; Liu C; Li Z; Adams A; Berger JP; Zhang BB; Moller DE; Doebber TW
Endocrinology; 2006 Sep; 147(9):4252-62. PubMed ID: 16728496
[TBL] [Abstract][Full Text] [Related]
40. Intestinal electrical stimulation attenuates hyperglycemia and prevents loss of pancreatic β cells in type 2 diabetic Goto-Kakizaki rats.
Ouyang X; Li S; Tan Y; Lin L; Yin J; Chen JDZ
Nutr Diabetes; 2019 Feb; 9(1):4. PubMed ID: 30728346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
